The current price of CRL is $336.67 — it has increased by 7.56% since the previous close. Data as of Nov 6, 2026.
CRL is down 9.74% over the past week, up 10.40% over the past month and up 97.02% over the past year. The price is above its 200-day moving average of $223.99.
Charles River Laboratories International, Inc. has a market capitalization of $16.13B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Charles River Laboratories International, Inc. posted earnings of $3.09 per share against an estimate of $2.97, beating expectations by 4.04%. Upcoming reports are listed in the earnings calendar.
Charles River Laboratories International, Inc. reported revenue of $982.73M in its most recent quarter, which has decreased by 2.20% compared with the same quarter a year earlier. Analysts had expected $960.36M.
Charles River Laboratories International, Inc. has not paid any dividends over the past year.
Companies most comparable to Charles River Laboratories International, Inc. include WuXi XDC Cayman Inc, WuXi AppTec Co., Ltd., Pharmaron Beijing Co., Ltd., Joinn Laboratories(China)Co.,Ltd. and WuXi Biologics (Cayman) Inc.
In the latest trading session CRL moved between $316.61 and $338.88, a range of 6.61% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Charles River Laboratories International, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks CRL has traded between $146.20 and $379.63. The current price is 11.32% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.